Copy Link Print Information

Edaravone

(Synonyms: MCI-186)
48 Cited Publications
고객리뷰

Based on 48 publication(s) in Google Scholar

Edaravone is a strong novel free radical scavenger, and inhibits MMP-9-related brain hemorrhage in rats treated with tissue plasminogen activator.

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

  • Purity: 99.94%
  • CAS No.: 89-25-8
  • 화학식: C10H10N2O
  • 분자량:174.20
  • 보관:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 1 year , -20°C, 6 months
  • Edaravone Chemical Structure
    Edaravone Chemical Structure
  • Experimental Validation Results for Edaravone
  • Experimental Validation Results for Edaravone
  • Experimental Validation Results for Edaravone
  • Experimental Validation Results for Edaravone
  • Experimental Validation Results for Edaravone
  • Experimental Validation Results for Edaravone
CAS No.: 89-25-8
사이즈
가격
재고
수량
Amount: USD 0.00
Please select quantity
or
or

* 장바구니에 담기 전 물품의 수량을 선택해 주십시오.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Other Forms of Edaravone:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
주변의 대리점 찾기 Your local distributor: Hycultec GmbHHycultec
  • Biological Activity
  • Chemical Information
  • 용액&용해도
  • Protocol
  • 순도&문서
  • References
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) Edaravone

More
Customer Validation & Images
Cell Proliferation/Viability AssayIPIHCWBIF
  • WB
  • IF
  • IHC
  • Cell Proliferation/Viability Assay
  • IP
  • IHC

All MMP Isoforms

More
Keywords
MOQ
Minimum order quantity
100 mg

견적 받기 해외재고보유

Other size
견적 받기
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress 로그인
Register
Sign in to MedChemExpress
회원가입

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • Edaravone Chemical Structure
    Edaravone Chemical Structure
    1/16
  • 1/16

    Edaravone purchased from MedChemExpress. Usage Cited in: Int Wound J. 2023 Oct;20(8):3088-3104. [Abstract]

    Customer Validation
     Edaravone (EDA; 20.0 mg/kg/day; i.p.; 7 days) significantly increases the protein expression of TGF-β1, VEGF and MMP9 in mice.

  • 1/16

    Edaravone purchased from MedChemExpress. Usage Cited in: Int Wound J. 2023 Oct;20(8):3088-3104. [Abstract]

    Customer Validation
     Edaravone (EDA; 20.0 mg/kg/day; i.p.; 7 days) significantly reduces the number of apoptotic cells in mice.

  • 1/16

    Edaravone purchased from MedChemExpress. Usage Cited in: Int Wound J. 2023 Oct;20(8):3088-3104. [Abstract]

    Customer Validation
     Edaravone (EDA; 20.0 mg/kg/day; i.p.; 7 days) significantly promotes VEGF and MMP9 expression in mice.

  • 1/16

    Edaravone purchased from MedChemExpress. Usage Cited in: Front Physiol. 2020 Jan 15:10:1596. [Abstract]

    Customer Validation
     After treating C2C12 cells with 250 µM H2O2, viability is significantly decreased, and improvement in survival rate was observed in the group treated with Edaravone at 100 µM (∗compared with 0 µM H2O2, p < 0.01; # compared with 250 µM H2O2, p < 0.01).

  • 1/16

    Edaravone purchased from MedChemExpress. Usage Cited in: Front Physiol. 2020 Jan 15:10:1596. [Abstract]

    Customer Validation
     TNF-α expression is significantly increased by treating C2C12 cells with 250 µM H2O2. In addition, pretreatment with edaravone at 100 µM, TNF-α expression is significantly suppressed (∗ compared with 0 µM H2O2, p < 0.01; # compared with 250 µM H2O2, p < 0.01).

  • 1/16

    Edaravone purchased from MedChemExpress. Usage Cited in: Front Physiol. 2020 Jan 15:10:1596. [Abstract]

    Customer Validation
     A) HE staining of muscle tissue after artery ligation shows that the cells are round, and reveals infiltration of inflammatory cells in both control (Con) and ob/ob (Ob) mice. (B) MyoD immunostaining is lower in Ob than Con at 7 days after ligation of the femoral artery. However, pretreatment with Edaravone increases the expression of MyoD in obese mice.

  • Edaravone